The invention discloses a 
triptolide self-dissolving microneedle.  According to the present invention in parts by weight, the tip matrix prescription of the 
triptolide self-dissolving microneedle is 24-29 parts of PVP, 7.8-8.3 parts of PVA, 0.45-0.65 parts of CMC-Na, 0.28-0.42 parts of 
triptolide  40-45 parts of 
distilled water and 20-23 parts of absolute 
ethanol; the backing layer matrix prescription of the triptolide self-dissolving microneedles is 32-37 parts of PVP, 9-12 parts of PVA and 53-58 parts of 
distilled water.  The present invention has good moldability and 
mechanical strength of the microneedle, RSD value of the 
drug loading is 0.98%, and the process is stable and feasible. The tip of the 
drug-loaded microneedle can make most of the 
drug reach the body quickly and take effect quickly. In addition, the microneedle matrix  The sustained release effect of triptolide can improve the drug safety of triptolide, and reduce the expression and increase of 
inflammatory factors TNF-ɑ, IL-17, PGE2, IgG, IgM, and IgA by reducing the 
inflammatory infiltration of cells in the synovium.  The expression of OPG, the trend of decreased 
RANKL expression and the 
RANKL / OPG ratio, realize the therapeutic advantages for 
rheumatoid arthritis.